Archives

img-01

Asia’s Middle Class

Asia’s healthcare landscape is changing with its growing middle class. China, India and ASEAN’s middle classes are expected to grow by around 100 million people in the next ten years. Asia’s demand for healthcare will continue to grow with more people able... Read More

img-01

Asia Cancer Market Update

This article was also published on MedTech Intelligence. Government healthcare expenditures in Asian countries has been increasing steadily in recent years. According to a 2016 Deloitte report, the average annual increase in government healthcare spending in Asian countries is more than 6%,... Read More

img-01

The Promise of Regenerative Medicine in Asia

This article was also published on MedTech Intelligence. Regenerative medicine focuses on harnessing the body’s ability to heal itself by restoring the functionality of damaged tissues and organs. Current medicine treats symptoms but oftentimes does not repair the underlying problems, which is... Read More

img-01

India Proposes to Cut Cardiac Stent Prices

The Indian drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) proposed in January 2017 to categorize stents into two categories: drug-eluting stents (DES) and bare-metal stents (BMS). Along with this proposal, the NPPA also proposed to fix the prices of these... Read More

img-01

Asia Increases Efforts to Promote Vaccinations

Multiple countries in the APAC region have been experiencing outbreaks of preventable diseases in 2016.  The number of Singapore’s measles cases doubled in the first half of 2016 compared to the same time period in 2015, while Malaysia’s tripled from 2015 to... Read More

img-01

Myanmar’s Medtech on the Rise as Market Opens Up

This article was also published on MedTech Intelligence. Historically, Myanmar (known as Burma until 1989) has been isolated from the rest of the world. Recent political changes have, however, opened Myanmar up to the West, stimulating economic growth. In particular, the medical device... Read More

img-01

Asia Behind in Health Economics

While the US and EU have been using health economics outcomes for drugs and devices for a number of years, Asia is behind in this area.  Much of this is caused by the lack of standardized systems, regulations, and resources needed to... Read More

img-01

India Fast-Tracks Clinical Trials

In India, 90% of clinical trials over the past few years have ended abruptly primarily due to contract research organizations (CROs) and drug companies using Indian patients as “guinea pigs”. Despite this dramatic slowdown in clinical trials, the Indian government is taking... Read More